OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
Johanna Latzka, Chalid Assaf, M. Bagot, et al.
European Journal of Cancer (2023) Vol. 195, pp. 113343-113343
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study
Keila Mitsunaga, M. Bagot, C. Ram‐Wolff, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 3, pp. 419-427
Closed Access | Times Cited: 7

Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review
M. Fernández‐Guarino, Pablo L. Ortiz‐Romero, Fernando Gallardo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2203-2203
Open Access | Times Cited: 6

Cytokine-pathway blockers worsen mycosis fungoides masquerading as psoriasis.
Gabriela Blanchard, Bettina Bisig, Laurence de Leval, et al.
JAAD Case Reports (2024) Vol. 48, pp. 98-102
Open Access | Times Cited: 4

Italian expert opinion on the treatment of mycosis fungoides with chlormethine gel: results of a Delphi consensus
Silvia Alberti Violetti, Marco Ardigò, Raffaele Filotico, et al.
EJC Skin Cancer (2025), pp. 100280-100280
Closed Access

Seborrhoische keratosenartige Mycosis fungoides: Eine seltene Variante mit klinischen, dermatoskopischen und dermatopathologischen Merkmalen
Hatice Şanlı, Ahmet Taha Aydemir, Aylın Okçu Heper, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2025) Vol. 23, Iss. 1, pp. 108-111
Closed Access

Emergence of bullous pemphigoid under treatment of mycosis fungoides with mogamulizumab
Lukas D. Uleer, Carmen Loquai, Iakov Shimanovich, et al.
JEADV Clinical Practice (2025)
Open Access

“Missed” Diagnosis of Mycosis Fungoides: A Case Report
M Mathur, Neha Thakur, Sandhya Regmi, et al.
Clinical Case Reports (2025) Vol. 13, Iss. 2
Open Access

The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas
Liang Lin, Gabriele Roccuzzo, Yuliya Yakymiv, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 309-309
Open Access

Praxisempfehlungen für die Therapie und Überwachung von Mogamulizumab‐Patienten in Deutschland
Chalid Assaf, Nina Booken, Edgar Dippel, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2025) Vol. 23, Iss. 3, pp. 341-356
Open Access

Haematopoietic stem cell transplant in cutaneous T‐cell lymphomas: A multicentre propensity‐score matched study
Lía Bejarano, Mercè Grau‐Pérez, Marina Paíno‐Román, et al.
Journal of the European Academy of Dermatology and Venereology (2025)
Closed Access

Drug‐ and Vaccine‐Induced Cutaneous T‐Cell Lymphoma: A Systematic Review of the Literature
Ifa Etesami, Mahshid Sadat Ansari, Elnaz Pourgholi, et al.
Journal of Skin Cancer (2025) Vol. 2025, Iss. 1
Open Access

Total skin electron beam therapy
Lena Specht
Frontiers in Oncology (2025) Vol. 15
Open Access

Effectiveness and tolerability of chlormethine gel for the management of mycosis fungoides: a multicenter real-life evaluation
Silvia Alberti Violetti, Marco Ardigò, Cesare Massone, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 3

The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets
Alba Guglielmo, Corrado Zengarini, Claudio Agostinelli, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 584-584
Open Access | Times Cited: 3

Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study)
Sofia Tzoumpa, S. Oro, Adèle de Masson, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 1, pp. 143-144
Closed Access | Times Cited: 3

Radiotherapy in Cutaneous Lymphomas: Recommendations from the EORTC Cutaneous Lymphoma Tumour Group
Khaled Elsayad, Emmanuella Guenova, Chalid Assaf, et al.
European Journal of Cancer (2024) Vol. 212, pp. 115064-115064
Closed Access | Times Cited: 3

Advances in the pharmacological management of cutaneous T-cell lymphoma
Gabriele Roccuzzo, A Roggo, Egle Ramelyte, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 7, pp. 885-894
Closed Access | Times Cited: 2

An Overview of Methotrexate Indications in Skin Diseases
Mădălina Mocanu, Dorina Procopciuc, Dragoș-Florin Gheucă-Solovăstru, et al.
Medicina (2024) Vol. 60, Iss. 7, pp. 1024-1024
Open Access | Times Cited: 2

Immune-related adverse events associated with Mogamulizumab: a comprehensive review of the literature
Genevieve S. Silva, Ellen J. Kim, Stefan K. Barta, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 9, pp. 819-827
Closed Access | Times Cited: 2

Pegylated interferon‐α2a in cutaneous T‐cell lymphoma – a multicenter retrospective data analysis with 70 patients
Inga Hansen, Glenn Geidel, Finn Abeck, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 11, pp. 1489-1497
Open Access | Times Cited: 2

Breaking Down the Barriers for Patients With Cutaneous T-Cell Lymphoma: Current Controversies and Challenges for Radiation Oncologists in 2024
Belinda A. Campbell, H. Miles Prince, Karin Thursky, et al.
Seminars in Radiation Oncology (2024) Vol. 35, Iss. 1, pp. 110-125
Open Access | Times Cited: 2

Predictive and prognostic biomarkers in patients with Mycosis fungoides and Sézary syndrome (BIO-MUSE): Study protocol for a translational study (Preprint)
Emma Belfrage, Sara Ek, Åsa Johansson, et al.
JMIR Research Protocols (2024) Vol. 13, pp. e55723-e55723
Open Access | Times Cited: 1

A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments
Corrado Zengarini, Alba Guglielmo, Martina Mussi, et al.
Antibodies (2024) Vol. 13, Iss. 2, pp. 32-32
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top